In light of its success in reducing the risk of heart attack or
stroke, researchers are investigating whether aspirin may offer
protection against cancer. In March 2010, Harvard researchers
reported results suggesting that if aspirin does possess
cancer-fighting properties, they might be most evident among
cancer survivors. Their study included about 4,000 women in the
Nurses' Health Study who had been diagnosed with breast cancer
over a 26-year period and who had supplied researchers with
information about their use of aspirin. The Harvard researchers
found that the breast cancer survivors who had taken aspirin
regularly after being diagnosed with the disease were 70% less
likely to have died from the breast cancer. Regular use was
defined as taking aspirin two to five days a week.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.